Rein Therapeutics, Inc. · NASDAQ:RNTX
Von Rickenbach Josef H bought 47,060 Rein Therapeutics, Inc. shares (Form 4)
Traded May 21 to May 27, 2026 · Filed May 28, 2026
From May 21 to May 27, 2026, Von Rickenbach Josef H (Director) bought 47,060 Rein Therapeutics, Inc. shares at an average US$1.06 for US$49,701, leaving 62,514 shares. Filed May 28, 2026 (Form 4).
- Bought
- 47,060 shares
- Price
- US$1.06 average (US$1.04 to US$1.07)
- Value
- US$49,701
- Holding after
- 62,514 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 21, 2026 | Common stock , $0.001 par value | Buy | 3,420 | US$1.04 | 18,874 | Direct |
| May 22, 2026 | Common stock , $0.001 par value | Buy | 15,950 | US$1.05 | 34,824 | Direct |
| May 26, 2026 | Common stock , $0.001 par value | Buy | 23,190 | US$1.06 | 58,014 | Direct |
| May 27, 2026 | Common stock , $0.001 par value | Buy | 4,500 | US$1.07 | 62,514 | Direct |
Source
Related
- Rein Therapeutics, Inc.
- Von Rickenbach Josef H
- Rein Therapeutics, Inc. shareholders
- Schedule 13G/A · Lynwood Capital Management Inc. · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Schedule 13G/A · Voss Capital, LP · Jul 14, 2026
- Form 4 · Windsor James Brian · May 13, 2026